Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compugen | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪784.78M | 136.1x | 1.19 | ILA 853.50 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lineage Cell Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪502.30M | -5.9x | -0.35 | ILA 235.60 | 7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Batm | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪350.40M | -228.6x | 1.51 | ILA 84.30 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oramed Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪326.65M | 20.8x | 0.16 | ILA 820 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bonus Biogroup | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪198.55M | -7.1x | ILA 17 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
DNA Group TR | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪129.20M | 8.6x | 0.02 | ILA 105.10 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enlivex | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪92.83M | -1.2x | -0.04 | ILA 426 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pluri Inc | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪88.73M | -1.1x | -0.04 | ILA 1,597 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioline Rx | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪81.13M | -0.6x | -0.02 | ILA 3.80 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kadimastem Ltd | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪67.02M | -37.8x | -0.08 | ILA 1,563 | -5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Matricelf | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪56.75M | ILA 350.60 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
XTL Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪56.41M | -8.9x | -0.31 | ILA 6.30 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Evogene | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪40.34M | -0.4x | -0.1 | ILA 628 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Purple Biotech | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪33.10M | -0.3x | -0.02 | ILA 6.30 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nextage Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪25.27M | ILA 75.30 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Merchavia | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪18.42M | -1.7x | -0.58 | ILA 96.40 | -11.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hadasit Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪5.81M | -0.8x | -0.01 | ILA 52.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Univo Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪2.84M | ILA 93,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |